Invesco Ltd. Abbott Laboratories Call Options Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $94,500 - $102,978	-900 Reduced 20.0%	3,600 $394,000
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 2.17%	4,500 $490,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $50,256 - $73,488	-800 Reduced 14.81%	4,600 $363,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $32,736 - $35,496	400 Added 8.0%	5,400 $452,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $123,895 - $144,500	1,700 Added 51.52%	5,000 $420,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $178,794 - $216,162	2,700 Added 450.0%	3,300 $264,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $39,336 - $44,562	600 New	600 $43,000

3,136

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.